ASND vs BAC Stock Comparison
ASND currently leads BAC in this stock comparison, with AIQ scores of 72 vs 58. The clearest difference is momentum, while BAC has the stronger risk resilience profile.
What is the main difference between ASND and BAC?
ASND leads the current stock comparison as Ascendis Pharma A/S, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Ascendis Pharma A/S vs Bank of America Corporation
ASND leads
ASND leads by 14 AIQ points, primarily on Momentum and Quality, having only recently taken the lead back from BAC. Wall Street currently favors BAC on target upside.
Fragile: 3 of 6 evidence groups support ASND, the lead recently changed hands, and its current signal state is conflicted.
Ascendis Pharma A/S
Bank of America Corporation
The Algovestiq AIQ Score currently favors ASND over BAC, 72 versus 58 as of Nov 15, 2026. ASND's advantage is driven primarily by stronger momentum and quality, while BAC holds the stronger risk resilience profile. ASND also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BAC. 3 of 6 covered evidence groups favor ASND today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. ASND lead: Reversed — BAC led by 1 AIQ points 30 sessions ago; ASND now leads by 14.
Compare Ascendis Pharma A/S and Bank of America Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare ASND and BAC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum75 vs 37ASND +38
- Risk Resilience72 vs 83BAC +11
- Quality71 vs 64ASND +7
- Value66 vs 68Even
3 of 6 evidence groups favor ASND. ASND’s edge is concentrated in momentum and quality; BAC keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +4
New signals
- 52-Week High Proximity — bullish, risk_regime, long horizon (1.3%)
- BB Upper Band Breach — bearish, volatility, short horizon
No factor moved materially.
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
ASND's lead widened by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — ASND and BAC both carry a full feed there.
The central trade-off
ASND (Ascendis Pharma A/S): the stronger current systematic profile, led by momentum and quality.
BAC (Bank of America Corporation): the counter-case, on risk resilience, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ASNDASND on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BACBAC on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
ASNDASND on the Momentum factor, by 38 points.
Lower downside
BACBAC on Risk Resilience, by 11 points.
Analyst upside
BACBAC on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ASND, analyst targets favor BAC. That disagreement is the most useful thing on this page.
| Measure | ASND | BAC | Note |
|---|---|---|---|
| Implied upside to target | +13.2% | +24.1% | BAC has more room |
| Target dispersion | +27% | +25.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 22 | 25 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor ASND. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ASND | 72 vs 58 |
| Fundamentals | ASNDon balance | revenue growth 6.5% vs -3.3%; EPS growth -66.1% vs -23.8%; TTM ROE 4.8% vs 2.3%; gross margin 90.6% vs 60.4%; operating margin 18.4% vs 22.4% — ASND takes 3 of 5 decided legs, not all of them |
| Valuation | Even | Value 66 vs 68 |
| Technicals | ASND | Price vs 50-day 13.5% vs -5.6%; vs 200-day 14.8% vs -7% |
| Risk Resilience | BAC | Risk Resilience 72 vs 83 |
| Analyst expectations | BAC | Target upside 13.2% vs 24.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ASND and BAC and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is wide at 14 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ASND.
How the comparison changed
120 daily snapshots · May 27 – Nov 13ASND lead: Reversed — BAC led by 1 AIQ points 30 sessions ago; ASND now leads by 14.
- Today
- ASND +14
- 72 vs 58
- 7 sessions ago
- ASND +11
- 69 vs 58
- 30 sessions ago
- BAC +1
- 61 vs 62
- 90 sessions ago
- BAC +5
- 66 vs 71
The lead changed hands 2 times in this window, most recently on Oct 15 when BAC moved ahead of ASND.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
8 bullish / 2 bearish / 1 neutral, conflicted
Only ASND
- Golden Cross Active — bullish, trend, long horizon (1.18%)
- 52-Week High Proximity — bullish, risk_regime, long horizon (1.3%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- Accumulation Pattern — bullish, volume, medium horizon (1.18x)
- BB Upper Band Breach — bearish, volatility, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- RSI Overbought — bearish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
2 bullish / 2 bearish / 1 neutral, conflicted
Only BAC
- Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
- Death Cross Active — bearish, trend, long horizon (1.45%)
- Downtrend Structure Active — bearish, trend, long horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
Both carry 1 more signal that do not separate them: MACD Histogram Expanding Bullish.
ASND leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +3.12%, AIQ +2 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BAC closes the Momentum gap — currently 38 points behind, the largest single contributor to ASND's edge.
- 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3ASND's conflicting signal state resolves bearish — it currently carries 8 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
ASND leads on balance| Metric | ASND | BAC |
|---|---|---|
| Revenue growth (YoY) | 6.5% | -3.3% |
| EPS growth (YoY) | -66.1% | -23.8% |
| Gross margin | 90.6% | 60.4% |
| Operating margin | 18.4% | 22.4% |
| Return on equity (TTM) | 4.8% | 2.3% |
| Debt to equity | 0.3 | 1.28 |
Performance
ASND leads 6 of 6 windows| Metric | ASND | BAC |
|---|---|---|
| 1 week (5 sessions) | 7.2% | 3.2% |
| 1 month (20 sessions) | 22.3% | -0.4% |
| 3 months (63 sessions) | 11.3% | -20.1% |
| 6 months (126 sessions) | 14.5% | 2.5% |
| Year to date | 29.1% | -7.2% |
| 1 year (252 sessions) | 38.2% | -5.7% |
Technicals
ASND has the stronger structure| Metric | ASND | BAC |
|---|---|---|
| RSI (14) | 74.7 | 45.9 |
| ADX (14) | 37.9 | 27.2 |
| Price vs 50-day | 13.5% | -5.6% |
| Price vs 200-day | 14.8% | -7% |
| Volatility (1M, annualized) | 22.3% | 24.8% |
Risk
BAC is the more resilient| Metric | ASND | BAC |
|---|---|---|
| Beta | 0.4 | 0.79 |
| Sharpe ratio | 0.84 | -0.22 |
| Sortino ratio | 1.27 | -0.29 |
| Max drawdown | -19.7% | -23.7% |
| Current drawdown | -0.6% | -21.3% |
| Annualized volatility | 38.6% | 22.4% |
| Value at risk (95%) | -3.6% | -2.6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ASND or BAC?
On the Algovestiq AIQ Score, ASND is the stronger of the two as of Nov 15, 2026, scoring 72 against BAC's 58. The edge comes from momentum and quality. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ASND or BAC the better buy right now?
ASND carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor ASND over BAC?
The composite weights Quality, Value, Momentum and Risk Resilience. ASND leads Momentum by 38 points; BAC leads Risk Resilience by 11 points; ASND leads Quality by 7 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ASND or BAC?
Analyst price targets imply +13.2% upside for ASND and +24.1% for BAC, so the Street currently favors BAC. That points the opposite way to the AIQ Score, which favors ASND. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ASND or BAC?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ASND or BAC?
BAC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ASND or BAC?
ASND on the Momentum factor, by 38 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ASND or BAC?
BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ASND more profitable than BAC?
The profitability evidence is mixed: gross margin 90.6% vs 60.4%; operating margin 18.4% vs 22.4%; ttm roe 4.8% vs 2.3%. ASND leads on two measures and BAC on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is ASND's lead over BAC getting stronger or weaker?
ASND lead: Reversed — BAC led by 1 AIQ points 30 sessions ago; ASND now leads by 14. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-10-15, when BAC moved ahead of ASND.
What would change the ASND vs BAC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 38 points behind, the largest single contributor to ASND's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; ASND's conflicting signal state resolves bearish — it currently carries 8 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about ASND and BAC?
ASND: 8 bullish / 2 bearish / 1 neutral, conflicted. BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ASND is Golden Cross Active (bullish, long horizon). On BAC it is Death Cross Active (bearish, long horizon).
Compare ASND and BAC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.